528 related articles for article (PubMed ID: 28648665)
1. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
[TBL] [Abstract][Full Text] [Related]
2. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
Xu M; Jin H; Xu CX; Sun B; Mao Z; Bi WZ; Wang Y
Oncotarget; 2014 Oct; 5(19):9472-83. PubMed ID: 25344865
[TBL] [Abstract][Full Text] [Related]
3. MiR-34c inhibits osteosarcoma metastasis and chemoresistance.
Xu M; Jin H; Xu CX; Bi WZ; Wang Y
Med Oncol; 2014 Jun; 31(6):972. PubMed ID: 24802328
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
Cheng M; Duan PG; Gao ZZ; Dai M
Oncol Rep; 2020 Dec; 44(6):2691-2700. PubMed ID: 33125503
[TBL] [Abstract][Full Text] [Related]
5. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.
Wang L; Kang FB; Sun N; Wang J; Chen W; Li D; Shan BE
Tumour Biol; 2016 Nov; 37(11):14939-14947. PubMed ID: 27644254
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
8. miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3.
Dong D; Gong Y; Zhang D; Bao H; Gu G
Tumour Biol; 2016 May; 37(5):6447-55. PubMed ID: 26631042
[TBL] [Abstract][Full Text] [Related]
9. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
10. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
Ji Q; Xu X; Song Q; Xu Y; Tai Y; Goodman SB; Bi W; Xu M; Jiao S; Maloney WJ; Wang Y
Mol Ther; 2018 May; 26(5):1299-1312. PubMed ID: 29628305
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
13. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H
Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4.
Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ
Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2.
Zhong C; Liu J; Zhang Y; Luo J; Zheng J
Life Sci; 2017 Dec; 191():68-73. PubMed ID: 28993144
[TBL] [Abstract][Full Text] [Related]
16. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504
[TBL] [Abstract][Full Text] [Related]
18. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
20. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]